Catalyst Wire Dossier Catalyst Wire Dossier

RVSV-Nipah Virus Vaccine Candidate PHV02

recombinant vesicular stomatitis virus-based Nipah virus vaccine · Public Health Vaccines LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RVSV-Nipah Virus Vaccine Candidate PHV02, covering 2024-10-24 to 2024-10-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects [Phase 1]

See pricing